graphic
abstract
highlight
hepat
c
viru
bind
alter
host
protein
interact
receptor
six
virusdepend
protein
promot
viru
entri
bind
aid
infect
hcv
vsv
genotyp
membraneassoci
requir
hcv
entri
open
access
articl
cc
byncnd
licens
http
hepat
c
viru
hcv
enter
human
hepatocyt
multistep
mechan
involv
among
host
protein
viru
receptor
govern
hcv
entri
poorli
character
protein
interact
viru
bind
remain
elus
develop
quantit
proteom
protocol
identifi
hcvtrigger
interact
found
dynam
bind
partner
least
six
protein
promot
hcv
infect
indic
rnai
character
serum
respons
factor
bind
protein
recruit
hcv
uptak
support
hcv
infect
hepatoma
cell
primari
human
hepatocyt
facilit
host
cell
penetr
seven
hcv
genotyp
vesicular
stomat
viru
human
coronaviru
thu
hcvspecif
pangenotyp
host
entri
factor
result
demonstr
use
quantit
proteom
elucid
pathogen
entri
underscor
import
host
proteinprotein
interact
hcv
invas
correspond
gisagerold
twincored
gg
thomaspietschmann
twincor
de
tp
brief
hepat
c
viru
hcv
enter
human
hepatocyt
multistep
mechan
gerold
et
al
appli
quantit
proteom
defin
protein
network
respons
hcv
entri
identifi
partner
viru
receptor
viru
entri
describ
process
deliv
viral
genom
replicationcompet
manner
naiv
host
cell
success
penetr
cell
involv
receptor
bind
virion
uptak
membran
fusion
perturb
transport
nucleocapsid
replic
compet
cellular
compart
uncoat
yamauchi
heleniu
viru
receptor
attach
factor
function
support
cell
entri
sever
mean
mediat
format
receptor
platform
induc
conform
chang
viru
surfac
molecul
transmit
signal
within
cell
induc
viru
transloc
along
membran
cell
mercer
et
al
number
viru
receptor
howev
lack
signal
domain
consequ
receptor
must
initi
viru
uptak
program
liganddepend
interact
addit
host
protein
studi
focu
entri
mechan
hepat
c
viru
hcv
envelop
rna
viru
infect
million
individu
worldwid
gravitz
lavanchi
hepat
c
slowli
progress
diseas
caus
liver
fibrosi
cirrhosi
hepatocellular
carcinoma
year
contract
seeff
date
hepat
c
number
one
indic
liver
transplant
north
america
europ
unfortun
reinfect
graft
liver
viru
resid
peripher
reservoir
almost
univers
lead
acceler
diseas
progress
posttranspl
patient
interf
entri
hcv
engraft
hepatocyt
would
promis
prevent
treatment
hcv
penetr
multistep
process
requir
four
entri
factor
scaveng
receptor
class
b
member
srbi
occludin
ocln
evan
et
al
pileri
et
al
ploss
et
al
scarselli
et
al
central
player
hcv
entri
directli
bind
hcv
surfac
glycoprotein
render
fusion
compet
pileri
et
al
rajesh
et
al
sharma
et
al
activ
hcv
entri
cofactor
epiderm
growth
factor
receptor
egfr
diao
et
al
gerold
rice
lupberg
et
al
moreov
thought
later
transloc
virion
tight
junction
ocln
resid
brazzoli
et
al
final
cointern
viru
endosom
farquhar
et
al
orchestr
hcv
uptak
remain
elus
scaffold
protein
lack
intracellular
signal
domain
coordin
proteinprotein
interact
membran
microdomain
term
tetraspanin
web
charrin
et
al
montpelli
et
al
hypothes
bind
hcv
trigger
protein
interact
turn
coordin
hcv
uptak
determin
chang
protein
interact
network
coordin
uptak
hcv
particl
use
quantit
proteom
meissner
mann
found
hcvdepend
interact
consist
hypothesi
subset
receptorinteract
protein
promot
hcv
infect
particular
identifi
serum
respons
factor
bind
protein
hcv
host
factor
form
complex
coordin
host
cell
penetr
method
describ
applic
variou
step
life
cycl
virus
microb
hold
promis
reveal
critic
pathogeninduc
chang
host
proteinprotein
interact
thu
guid
develop
antiinfect
strategi
quantit
proteom
allow
hypothesisfre
character
proteinprotein
interact
cellular
state
use
stabl
isotop
label
amino
acid
cell
cultur
silac
quantit
interact
proteom
ong
et
al
studi
host
protein
interact
hcv
receptor
upon
hcv
exposur
end
hcv
permiss
human
hepatoma
cell
label
heavi
arginin
n
c
lysin
n
c
achiev
incorpor
heavi
amino
acid
cellular
protein
heavi
left
unlabel
light
hcv
induc
clathrinmedi
endocytosi
min
bind
coller
et
al
incub
heavi
cell
min
hcv
clone
moi
light
cell
noninfecti
cell
cultur
supernat
forward
label
exclud
isotopespecif
effect
swap
label
two
condit
light
cell
hcv
expos
heavi
cell
mock
treat
revers
label
next
affin
enrich
interact
protein
figur
combin
protein
hcv
uninfect
sampl
digest
protein
peptid
liquid
chromatographi
lc
coupl
mass
spectrometri
ms
identifi
quantifi
distinguish
peptid
deriv
hcv
uninfect
condit
characterist
mass
offset
figur
lcm
analysi
reveal
total
host
protein
coimmunoprecipit
coip
high
number
typic
affin
enrich
ms
includ
protein
nonspecif
bind
ip
resin
tabl
keilhauer
et
al
subsequ
data
process
elimin
background
binder
describ
detect
coip
high
intens
independ
presenc
bound
hcv
figur
identifi
hcvregul
proteinprotein
interact
next
calcul
ratio
heavi
light
protein
abund
cell
without
bound
hcv
protein
quantif
reproduc
demonstr
median
correl
silac
ratio
r
forward
revers
label
sampl
respect
focus
protein
differ
two
experiment
condit
therebi
exclud
background
binder
equal
abund
hcv
mock
sampl
hypothes
identifi
protein
interactor
quantit
differ
hcv
mock
sampl
among
hcvdepend
transient
interactor
protein
associ
figur
upper
right
quadrant
dissoci
upon
viru
exposur
figur
lower
left
quadrant
stratifi
hcvdepend
interactor
base
statist
signific
interact
strength
biolog
relev
particular
inclus
criteria
minimum
chang
interact
strength
upon
hcv
exposur
liver
express
nonnuclear
local
note
addit
exclud
ribosom
protein
studi
although
might
potenti
role
viru
uncoat
total
protein
fulfil
inclus
criteria
half
dissoci
half
associ
upon
viru
bind
label
data
point
figur
tabl
intact
protein
exclus
quantifi
presenc
hcv
assign
infinit
ratio
strength
interact
could
determin
known
steadyst
interact
partner
absent
transient
interactom
instead
identifi
protein
previous
report
hcv
entri
cofactor
known
compon
clathrinco
pit
coller
et
al
taken
togeth
confirm
hypothesi
hcv
bind
alter
protein
interact
network
hcv
entri
cofactor
transient
interactor
next
investig
whether
certain
molecular
function
cellular
compart
enrich
transient
interactom
protein
membran
associ
cytoskelet
compon
onethird
plasma
membran
associ
figur
tabl
molecular
function
analysi
reveal
strong
enrich
protein
bind
function
catalyt
activ
structur
molecul
activ
figur
tabl
taken
togeth
gene
ontolog
go
enrich
analysi
reflect
fact
complex
later
transloc
along
plasma
membran
brazzoli
et
al
coller
et
al
need
interact
plasma
membran
cytoskelet
protein
reveal
interconnect
cellular
structur
process
enrich
hcv
entrydepend
protein
pool
integr
davidbas
cluster
analysi
stringbas
protein
interact
map
figur
notabl
found
cluster
six
cellular
junction
protein
previous
report
hcv
entri
protein
includ
adheren
junction
desmosom
cell
envelop
constitu
interconnect
report
proteinprotein
interact
furthermor
found
cytoskelet
protein
spectrin
clathrinco
pit
protein
line
report
clathrinmedi
endocytosi
hcv
blanchard
et
al
final
found
cluster
calciumand
metalbind
protein
well
nuclear
protein
secondari
cytoplasm
local
identifi
protein
extracellular
plasma
membran
local
dissoci
upon
hcv
bind
figur
blue
label
wherea
protein
local
endosom
intracellular
compart
associ
figur
red
label
confirm
notion
complex
need
move
plasma
membran
microdomain
get
endocytos
summari
identifi
select
transient
proteinreceptor
interact
hcv
entri
includ
known
hcv
entri
cofactor
cluster
junction
membran
protein
virusdepend
protein
promot
hcv
infect
hypothes
subset
virusdepend
protein
requir
product
viru
entri
test
silenc
respect
mrna
infect
human
hepatoma
cell
renilla
luciferas
rluc
report
strain
hcv
figur
eight
target
show
signific
reduct
hcv
infect
cell
upon
rnai
previous
report
hcv
cofactor
also
decreas
hcv
infect
meet
statist
signific
criteria
figur
tabl
sirna
serv
posit
control
reduc
hcv
infect
none
candid
target
scrambl
sirna
cytotox
alter
cell
prolifer
cystatin
csta
desmosom
regul
dissoci
almost
complet
upon
viru
bind
figur
silenc
led
signific
increas
hcv
infect
figur
chose
concentr
eight
transient
interact
partner
reduc
hcv
infect
silenc
figur
transcript
level
six
eight
target
reduc
less
scrambl
sirna
control
figur
six
put
hcv
host
factor
barriertoautointegr
factor
spectrin
beta
chain
nonerythrocyt
calpactin
light
chain
poli
adpribos
polymeras
tabl
test
transient
interactor
show
strongest
reduct
hcv
infect
upon
knockdown
z
score
z
score
summari
found
least
six
test
transient
interactor
promot
hcv
infect
clear
bia
associ
five
dissoci
one
factor
figur
step
hcv
infect
emerg
prime
candid
indepth
character
hcv
entri
factor
protein
show
strongest
inhibit
hcv
infect
silenc
first
quantifi
mrna
primari
hepatocyt
resect
specimen
five
hcvneg
donor
observ
higher
express
level
cell
figur
importantli
mrna
protein
level
correl
strongli
figur
observ
differ
express
led
us
examin
whether
endogen
level
limit
hcv
infect
hepatoma
cell
overexpress
cell
observ
dosedepend
increas
hcv
infect
figur
convers
silenc
primari
hepatocyt
observ
decreas
hcv
infect
figur
collect
suggest
low
express
could
contribut
limit
infect
current
hcv
cell
cultur
model
next
ask
step
hcv
life
cycl
requir
first
confirm
infect
incom
viru
impair
hepatoma
cell
pool
three
sirna
three
individu
sirna
reduc
protein
express
result
reduct
hcv
infect
figur
cell
show
decreas
surfac
express
reduct
infect
figur
next
exclud
offtarget
effect
sirna
complement
cell
sirnaresist
variant
figur
taken
togeth
silenc
led
decreas
hcv
suscept
phenotyp
could
rescu
complement
associ
hcv
entri
factor
suggest
role
hcv
entri
earli
postentri
event
infect
readout
hr
posthcv
inocul
determin
accumul
effect
viru
entri
translat
replic
spread
gerold
pietschmann
thu
next
sought
exclud
would
affect
hcv
translat
replic
silenc
cell
activ
replic
hcv
observ
impair
replic
rluc
report
translat
hr
postrnai
stark
contrast
silenc
known
replic
host
factor
phosphatidyl
inositol
kinas
alpha
reduc
replic
background
level
figur
upper
panel
reiss
et
al
neither
knockdown
affect
cell
viabil
prolifer
figur
middl
panel
address
possibl
role
assembl
releas
spread
hcv
collect
supernat
hcvreplic
cell
b
interactom
upon
hcv
exposur
depict
mean
log
silac
ratio
protein
hcv
versu
mocktreat
sampl
forward
axi
revers
experi
x
axi
revers
label
ratio
invert
posit
correl
indic
reproduc
interact
upon
label
swap
signific
fdr
outlier
color
red
protein
blue
protein
infinit
ratio
interact
partner
exclus
found
presenc
hcv
nd
quantifi
either
forward
revers
experi
c
silac
log
ratio
factor
shown
mean
sem
four
biolog
replic
invert
revers
label
ratio
e
enrich
gene
ontolog
cellular
compon
gocc
molecular
function
gomf
annot
f
function
map
host
factor
transient
interact
hcv
receptor
viru
entri
function
cluster
white
box
previous
report
interact
bold
line
identifi
transient
partner
depict
assign
individu
protein
highest
score
david
cluster
yellow
line
gene
differ
cluster
indic
highconfid
string
interact
within
function
annot
cluster
also
lower
confid
string
interact
shown
protein
place
predomin
cellular
locat
shown
twice
local
nucleu
cytoplasm
box
size
indic
degre
associ
dissoci
upon
hcv
bind
associ
factor
red
dissoci
factor
blue
shown
see
also
figur
tabl
hr
postsirna
transfect
infect
naiv
cell
silenc
alter
releas
infect
wherea
apolipoprotein
e
apo
silenc
expectedli
reduc
releas
infect
figur
lower
panel
chang
et
al
taken
togeth
silenc
render
cell
less
suscept
hcv
without
alter
replic
spread
viru
naiv
cell
light
find
play
role
earli
hcv
infect
investig
whether
coloc
establish
hcv
entri
factor
rest
cell
wherea
weakli
coloc
ocln
srbi
pearson
coeffici
fraction
protein
coloc
pearson
coeffici
particular
signal
overlap
perinuclear
region
cell
peripheri
observ
punctat
vesicular
stain
observ
weak
coloc
membran
marker
wheat
germ
agglutinin
wga
pearson
coeffici
figur
next
sought
exclud
act
chaperon
ocln
srbi
adipocyt
requir
express
insulinrespons
glucos
transport
type
shuttl
plasma
membran
lisinski
et
al
contrast
observ
coloc
hepatoma
cell
figur
line
observ
silenc
hepatoma
cell
alter
surfac
level
srbi
wherea
silenc
reduc
rnai
followup
screen
select
transient
interact
partner
identifi
nine
put
host
factor
silenc
indic
transcript
pool
three
sirna
fluc
cell
infect
hr
later
renilla
luciferas
report
hcv
determin
cell
viabil
hcv
infect
hpi
shown
rluc
signal
normal
cell
viabil
plate
effect
eight
sirna
pool
significantli
decreas
one
increas
hcv
infect
p
ab
z
score
r
associ
factor
red
dissoci
factor
blue
scrambl
control
gray
shown
box
whisker
plot
nine
biolog
replic
shown
c
combin
silac
coip
rnai
strategi
reveal
bia
factor
act
hcv
host
factor
hcvdepend
partner
six
decreas
hcv
infect
upon
rnai
minimum
transcript
reduct
shade
color
see
also
figur
tabl
surfac
express
respect
protein
due
lack
antibodi
target
ocln
ectodomain
address
ocln
express
knockdown
immunofluoresc
immunoblot
total
protein
level
plasma
membran
express
ocln
similar
without
knockdown
figur
data
shown
similarli
transcript
level
hcv
entri
cofactor
egfr
niemannpick
protein
sainz
et
al
remain
unaffect
silenc
figur
taken
togeth
data
exclud
act
chaperon
transcript
regul
one
previous
character
hcv
entri
factor
better
visual
hcv
entri
process
come
play
perform
addit
coloc
studi
detect
vesicular
structur
cell
peripheri
perinuclear
region
heterochromatin
region
nucleu
nuclear
local
consist
transcript
factor
function
describ
cardiomyocyt
zhang
et
al
perinuclear
signal
coloc
cytosol
transgolgi
marker
pearson
correl
coeffici
punctat
vesicular
pattern
figur
partner
express
human
liver
requir
hcv
infect
transcript
level
primari
human
hepatocyt
higher
cell
absolut
transcript
number
hepatocyt
five
donor
two
independ
passag
human
hepatoma
cell
determin
technic
triplic
display
mean
sd
b
hcv
infect
increas
dosedepend
manner
fluc
cell
upon
overexpress
fulllength
cell
transduc
lentivirus
encod
blasticidin
resist
gene
empti
vector
hr
later
infect
hcv
infect
measur
hpi
luciferas
assay
immunoblot
analysi
lysat
posttransduct
show
dosedepend
overexpress
green
actin
serv
load
control
red
immunoblot
repres
three
biolog
replic
c
hcv
infect
reduc
fluc
cell
hp
silenc
use
pool
three
sirna
individu
sirna
target
indic
orf
posit
measur
infect
hpi
luciferas
assay
two
scrambl
sirna
serv
control
immunoblot
analysi
confirm
reduc
protein
level
hp
rnai
mean
sd
three
technic
replic
shown
infect
data
immunoblot
repres
three
biolog
replic
lentivir
transduct
sirnaresist
rescu
hcv
infect
fluc
cell
cell
transfect
sirna
sirna
hr
later
transduc
blasticidin
resist
gene
encod
lentiviru
sirnaresist
encod
lentiviru
compl
hr
later
infect
hcv
infect
hpi
measur
luciferas
assay
shown
e
dispens
hcv
replic
assembl
releas
fluc
cell
transfect
genom
hcv
rna
indic
gene
silenc
hr
later
sirna
hp
transfect
hpt
supernat
harvest
cell
lyse
replic
effici
lysat
measur
luciferas
assay
upper
panel
viabil
hcvreplic
cell
upon
rnai
determin
use
cellular
fluc
report
hpt
middl
panel
supernat
hcvtransfect
cell
titrat
naiv
cell
determin
viru
particl
assembl
releas
rate
bottom
panel
valu
normal
scrambl
sirna
control
unless
state
otherwis
experi
display
mean
sd
three
independ
biolog
replic
perform
technic
triplic
see
also
figur
cell
peripheri
weakli
stain
posit
endosom
marker
eea
well
f
g
actin
figur
achiev
moresensit
visual
endosom
compart
transfect
egfprab
fusion
protein
nielsen
et
al
cell
found
overlap
signal
earli
late
endosom
figur
favor
role
earli
hcv
infect
resid
hcv
replic
assembl
compart
shown
costain
p
bodi
marker
stress
granul
marker
lipid
droplet
dye
oil
red
figur
next
ask
whether
could
interact
intracellular
membran
transmembran
domain
predict
two
weak
amphipath
helic
n
terminu
protein
http
npsapbilibcpfrcgibinnpsaautomatpl
pagenpsanpsaamphipaseekhtml
sapay
et
al
indepth
analysi
reveal
put
helix
fiveaminoacid
hydrophob
side
fllvi
flank
lysin
residu
http
heliquestipmccnrsfr
gautier
et
al
moreov
two
cystein
residu
could
serv
palmitoyl
site
figur
confirm
fraction
membran
associ
perform
membraneflot
assay
accord
predict
subfract
endogen
resid
upper
membraneassoci
gradient
fraction
figur
expect
gapdh
resid
upper
lower
fraction
respect
solubil
membran
use
triton
found
endogen
exclus
solubl
lower
fraction
control
shift
partial
fraction
interestingli
mycddktag
overexpress
construct
resid
cytosol
fraction
suggest
solubl
tag
impair
membran
associ
analysi
indic
fraction
associ
cellular
membran
presum
weak
amphipath
helix
test
reloc
hcv
entri
process
expos
cell
purifi
ectodomain
hcv
glycoprotein
result
increas
coloc
pearson
correl
coeffici
could
revert
coadminist
block
antibodi
figur
notabl
observ
similar
recruit
compart
primari
hepatocyt
exposur
figur
hepatoma
cell
hcv
exposur
figur
summari
data
suggest
partial
resid
intracellular
membran
human
hepatoma
cell
hcv
glycoprotein
exposur
promot
coloc
pangenotyp
hcvspecif
host
entri
factor
next
test
whether
also
support
infect
envelop
virus
cell
silenc
neither
reduc
infect
vesicular
stomat
viru
vsv
human
coronaviru
figur
hint
hcvspecif
host
factor
elucid
aid
earli
hcv
infect
experiment
address
hcv
translat
replic
complex
format
membran
fusion
use
bicistron
hcv
iresdriven
translat
report
exclud
role
viral
genom
translat
figur
replic
complex
format
subgenom
fulllength
hcv
replicon
similarli
remain
unalt
upon
silenc
figur
line
observ
coloc
hcv
protein
pearson
coeffici
figur
next
induc
hcv
fusion
plasma
membran
lowph
wash
concomitantli
block
endosom
acidif
assay
hcv
enter
cell
fusion
plasma
membran
limit
endosom
membran
acidif
figur
expect
silenc
led
reduc
hcv
infect
interact
prime
hcv
glycoprotein
membran
fusion
notabl
silenc
reduc
hcv
infect
indic
function
cell
entri
step
acidif
endosom
confirm
assay
setup
human
coronaviru
fusion
plasma
membran
independ
ph
wherea
vsv
requir
lowph
wash
coronaviru
vsv
infect
remain
unaffect
silenc
bypass
assay
figur
taken
togeth
data
show
aid
earli
step
hcv
infect
even
viral
envelop
fusion
artifici
induc
plasma
membran
pinpoint
requir
viru
particl
toward
usag
test
whether
lentivir
pseudoparticl
decor
hcv
glycoprotein
depend
interestingli
lentivir
pseudotyp
hcv
genotyp
hsu
et
al
transduc
cell
effici
silenc
reduc
hcv
pseudoparticl
entri
wherea
none
test
condit
affect
control
pseudoparticl
carri
vsv
glycoprotein
figur
thu
affect
receptor
bind
instead
support
partial
coloc
membran
marker
wga
weakli
ocln
srbi
cell
stain
alexaconjug
membran
marker
wga
panel
min
left
unstain
panel
fix
permeabil
stain
indic
protein
nuclei
stain
dapi
coloc
across
section
yellow
line
panel
depict
respect
imag
repres
confoc
imag
insert
magnif
scale
bar
mm
b
pearson
correl
coeffici
indic
cellular
protein
membran
marker
wga
calcul
intens
correl
analysi
symbol
repres
individu
frame
horizont
line
indic
mean
sem
c
cell
sirna
express
srbi
plasma
membran
surfac
express
srbi
cell
analyz
hpt
indic
sirna
cell
stain
antibodi
hcv
entri
factor
follow
flow
cytometr
analysi
cell
per
sampl
quantif
addit
control
see
figur
control
directli
conjug
isotyp
antibodi
histogram
secondari
antibodi
histogram
ocln
express
level
stabl
silenc
sirna
immunoblot
analysi
ocln
red
green
sirna
mediat
silenc
hr
shown
actin
serv
load
control
data
repres
least
three
independ
experi
see
also
figur
infect
step
reflect
hcv
pseudoparticl
furthermor
influenc
lentivir
transduct
collect
result
show
dispens
lentivir
pseudotyp
vsv
coronaviru
infect
requir
render
cell
fulli
suscept
hcv
lastli
address
whether
addit
cell
cultur
hcv
genotyp
clinic
relev
hcv
genotyp
requir
effici
penetr
interfer
reduc
infect
chimer
virus
display
glycoprotein
either
one
seven
hcv
genotyp
similar
degre
figur
thu
quantit
interact
proteom
could
identifi
six
put
hcv
host
factor
particular
pangenotyp
entri
factor
hcv
result
demonstr
quantit
interact
proteom
combin
rnai
provid
valuabl
approach
studi
hostpathogen
interact
quantit
ms
provid
direct
inform
proteinprotein
interact
interact
strength
upon
perturb
cellular
system
develop
silac
coip
strategi
identifi
host
factor
transient
interact
hcv
receptor
data
set
allow
gener
weight
viru
entri
network
identif
cellular
process
entri
among
identifi
transient
interact
partner
four
csta
dsp
cdsn
integr
part
cellular
junction
particular
desmosom
protein
dissoci
viru
entri
suggest
viru
receptor
complex
leav
desmosom
membran
compart
uptak
second
enrich
cluster
ca
bind
protein
could
contribut
report
ca
depend
er
stress
deregul
ca
homeostasi
induc
hcv
benalifuret
et
al
piccoli
et
al
focus
interact
partner
support
hcv
infect
found
compris
least
interactor
put
hcv
host
factor
tabl
latter
two
guid
cytoskeleton
movement
plasma
membran
line
report
membran
surf
hcv
brazzoli
et
al
compon
annexin
heterotetram
regul
membran
organ
endocytosi
conclud
quantit
proteom
identifi
function
virushost
cell
interact
sever
hcv
host
factor
describ
studi
play
role
life
cycl
envelop
virus
also
known
myosin
iia
regul
kaposi
sarcomaassoci
herpesviru
macropinocytosi
valiya
veettil
et
al
phosphoryl
hcv
host
factor
egfr
lupberg
et
al
promot
uptak
papillomavirus
upon
egfrdriven
phosphoryl
dziduszko
ozbun
woodham
et
al
protein
also
thought
cofactor
entri
cytomegaloviru
respiratori
syncyti
viru
et
al
malhotra
et
al
raynor
et
al
involv
nuclear
dna
repair
genom
integr
chen
engelman
sens
vaccinia
viru
genom
cytoplasm
ibrahim
et
al
poli
adpribosyl
ation
activ
sequest
cytoplasm
sindbi
viru
infect
muthumani
et
al
park
griffin
henc
identifi
six
put
hcv
host
factor
link
known
hcv
entri
machineri
eg
clathrinmedi
endocytosi
egfr
signal
report
role
infect
sens
envelop
virus
emerg
prime
candid
follow
proof
principl
analysi
protein
strongest
rnai
phenotyp
screen
protein
promot
plasma
membran
express
adipocyt
lisinski
et
al
associ
actin
transcript
factor
activ
cardiomyocyt
zhang
et
al
zhang
et
al
studi
identifi
transient
bind
partner
hcv
receptor
human
hepatoma
cell
result
demonstr
requir
product
uptak
hcv
without
affect
express
membran
local
known
hcv
entri
factor
show
primari
hepatocyt
figur
pool
local
endosom
recruit
upon
hcv
glycoprotein
exposur
local
transgolgi
endosom
actin
cell
stain
transgolgi
marker
endosom
marker
lbpa
describ
figur
f
g
actin
stain
alexaconjug
phalloidin
dnase
respect
b
pearson
correl
coeffici
indic
cellular
protein
calcul
intens
correl
analysi
symbol
repres
individu
frame
horizont
line
indic
mean
sem
c
local
endosom
cell
transfect
express
plasmid
stain
coloc
rab
protein
across
section
yellow
line
depict
upper
panel
arrowhead
indic
coloc
coloc
earli
endosom
quantif
rab
tripleposit
puncta
shown
box
whisker
plot
show
median
minimum
maximum
valu
six
independ
frame
e
bioinformat
predict
two
weak
amphipath
helic
black
bar
second
helix
aa
show
small
hydrophob
face
five
amino
acid
fllvi
hydrophob
face
highlight
light
gray
primari
sequenc
yellow
helix
model
two
cystein
residu
aa
aa
could
serv
palmitoyl
site
indic
arrowhead
f
membran
flotat
assay
suggest
membran
associ
cell
transduc
mycddktag
hr
later
lyse
hypoton
buffer
analyz
nycodenz
gradient
ultracentrifug
follow
immunoblot
analysi
gapdh
lysat
serv
solubil
control
l
preclear
lysat
marker
p
pellet
lysat
preclear
one
three
independ
experi
shown
g
exposur
solubl
hcv
glycoprotein
increas
coloc
cell
cell
incub
block
antibodi
pb
mock
min
fix
stain
describ
figur
arrowhead
indic
coloc
h
pearson
correl
coeffici
calcul
intens
correl
analysi
symbol
repres
individu
frame
horizont
line
indic
mean
sem
p
valu
indic
repres
imag
insert
show
magnif
scale
bar
mm
c
mm
g
see
also
figur
legend
continu
next
page
express
higher
transcript
level
hepatoma
cell
express
seem
limit
hcv
infect
thu
might
play
critic
role
hcv
infect
patient
collect
data
suggest
bona
fide
entri
factor
hcv
figur
hcv
entri
pathway
support
step
independ
receptor
bind
clathrinmedi
endocytosi
endosom
acidif
latter
three
step
reliabl
mimick
lentivir
hcv
pseudotyp
enter
cell
independ
observ
discrep
cell
cultur
hcv
hcv
pseudoparticl
confirm
studi
suggest
hcv
pseudoparticl
fulli
mimic
entri
pathway
hcv
sainz
et
al
attribut
either
lower
avid
hcv
pseudoparticl
display
lower
densiti
glycoprotein
lack
serum
lipoprotein
associ
hcv
pseudoparticl
differ
nucleocapsid
propos
two
possibl
mode
action
hcv
entri
first
could
involv
actin
retrograd
transport
hcv
particl
observ
coller
et
al
actin
cortex
remodel
induc
hcv
pseudoparticl
second
might
assist
hcv
uncoat
nucleocapsid
transport
reflect
pseudoparticl
system
gener
could
miss
link
hcv
receptor
bind
actindepend
movement
hcv
invas
inde
observ
interact
g
actin
moreov
egfr
rho
gef
rho
gtpase
report
upstream
activ
protein
famili
time
support
hcv
entri
brazzoli
et
al
lupberg
et
al
zona
et
al
futur
studi
includ
highresolut
imag
necessari
experiment
valid
either
model
endogen
function
cytoplasm
current
elus
rat
cardiomyocyt
local
actin
fiber
close
attach
site
cell
cortex
overexpress
lead
actin
depolymer
zhang
et
al
hint
belong
class
myocardinrel
transcript
factor
mrtf
cofactor
olson
nordheim
regul
actin
polymer
cycl
gactinbound
cytoplasm
state
nuclear
state
concordantli
found
nucleu
cytoplasm
g
actin
human
hepatoma
cell
like
mrtf
cofactor
could
regul
actin
dynam
downstream
plasma
membran
receptor
signal
line
engag
antibodi
recent
report
promot
actindepend
hepatoma
spread
brimacomb
et
al
thu
hcv
might
exploit
endogen
mechan
physic
forc
gener
traffic
entri
taken
togeth
establish
combin
highresolut
ms
comput
proteom
rnai
elucid
receptor
complex
rearrang
hcv
entri
believ
quantit
interact
proteom
attract
strategi
identifi
host
factor
infecti
agent
particular
strength
lie
unbias
identif
yet
uncharacter
protein
demonstr
protein
previous
unknown
function
hepatocyt
moreov
interact
proteom
allow
identif
host
factor
ubiquit
express
thu
access
genet
complement
screen
similarli
host
factor
essenti
endogen
function
poorli
suit
stabl
knockdown
knockout
screen
readili
found
quantit
proteom
thu
minim
system
perturb
abovedescrib
workflow
clear
benefit
classic
genet
screen
method
hand
function
inform
identifi
host
factor
limit
interact
given
viru
receptor
function
followup
screen
describ
therefor
critic
evalu
protein
interact
data
consequ
interact
proteom
complementari
method
thu
far
genomicsori
toolbox
system
virolog
law
et
al
system
biolog
method
interact
proteom
error
free
although
detect
limit
ms
fingerprint
increas
tremend
past
year
fals
neg
might
aris
depend
affin
enrich
method
use
fals
posit
interact
could
obvious
aris
cell
lysi
b
dispens
coronaviru
infect
cell
infect
moi
rluc
activ
cell
lysat
measur
hpi
infect
rel
scrambl
sirna
control
shown
c
immunoblot
analysi
hp
sirna
transfect
cell
transfect
sirna
transduc
indic
pwpi
express
construct
h
hr
later
lyse
analyz
immunoblot
actin
serv
load
control
residu
signal
bicistron
translat
report
assay
hcv
iresdriven
rluc
capdepend
fluc
see
also
figur
silenc
overexpress
perform
c
hr
later
cell
transfect
translat
report
rna
eight
hour
report
transfect
luciferas
activ
lysat
monitor
e
earli
replic
report
assay
use
subgenom
hcv
genom
express
fluc
silenc
overexpress
perform
c
hr
later
jfhsgrfluc
rna
transfect
cell
cell
lyse
hr
luciferas
activ
monitor
polymeras
mutant
jfhsgrfluc
replicon
dgdd
use
assess
translat
hcv
genom
independ
de
novo
replic
see
also
figur
addit
control
f
requir
plasma
membran
fusion
assay
hcv
infect
cell
silenc
pretreat
concanamycin
nm
hr
block
vacuolar
type
h
atpas
incub
hcv
hr
c
presenc
concanamycin
shift
c
wash
ph
ph
buffer
min
incub
concanamycin
hr
medium
chang
endosom
acidif
independ
infect
measur
hpi
see
also
figur
addit
control
g
lentivir
pseudotyp
infect
cell
independ
cell
silenc
hr
infect
pseudotyp
encod
fluc
display
glycoprotein
hcv
genotyp
hcv
genotyp
vsv
glycoprotein
hpi
cell
lyse
fluc
activ
measur
infect
calcul
subtract
background
read
glycoproteinfre
particl
rel
vsvg
particl
h
silenc
reduc
infect
chimer
hcv
virus
glycoprotein
seven
genotyp
fluc
cell
subject
sirnamedi
silenc
follow
infect
intergenotyp
hcv
chimera
moi
express
rluc
fortyeight
hour
postinfect
infect
determin
rluc
activ
measur
cell
treat
target
scrambl
sirna
serv
control
sirna
use
experi
data
three
five
biolog
replic
display
mean
sd
see
also
figur
disrupt
cellular
compart
thu
care
followup
analysi
critic
heredescrib
methodolog
clearli
receptor
interact
proteom
allow
followup
search
entri
factor
also
reveal
host
factor
involv
innat
immun
recognit
cellular
perturb
trigger
viru
like
eg
apoptosi
figur
given
coip
proteom
reveal
interconnect
pathogen
receptor
host
cofactor
envis
techniqu
spur
develop
peptidomimet
small
molecul
therapeut
intervent
pathogen
invas
de
chassey
et
al
cell
passag
eight
time
light
heavi
label
media
ie
argand
lysfre
dmem
paa
laboratori
supplement
mm
lglutamin
mm
pyruv
dialyz
fb
sodium
bicarbon
mgml
arg
respect
mgml
ly
respect
cambridg
isotop
lab
confluent
cultur
incub
clone
moi
dilut
serumfre
label
media
min
c
treat
similar
manner
virusfre
condit
cell
cultur
media
process
way
data
point
toward
role
last
step
entri
ie
nucleocapsid
uncoat
hcv
prepar
mock
electropor
onestep
immunoprecipit
membran
protein
perform
detail
supplement
experiment
procedur
experi
conduct
four
replic
two
heavyand
two
lightlabel
cultur
per
experiment
condit
mass
spectra
acquir
analyz
describ
supplement
experiment
procedur
hcv
mocktreat
silac
pair
given
label
combin
normal
ratio
calcul
individu
heavi
light
peptid
intens
describ
cox
mann
transient
protein
interact
ie
regul
bind
hcv
entri
defin
differ
significantli
main
distribut
steadyst
interactor
use
signific
b
fals
discoveri
rate
describ
cox
mann
analysi
protein
total
protein
identifi
group
associ
dissoci
protein
tabl
protein
requir
significantli
regul
least
one
experi
includ
analysi
quantifi
protein
detect
one
experiment
condit
hcv
mock
analyz
total
ion
intens
heavi
light
peptid
separ
detect
five
protein
exclus
hcv
sampl
four
liver
express
protein
exclus
detect
mock
sampl
protein
significantli
regul
upon
hcv
incub
rank
fold
chang
chang
consid
analysi
fortyseven
interact
partner
fulfil
criterion
function
follow
protein
addit
filter
express
human
liver
subcellular
local
protein
lack
liver
express
strict
ribosom
nuclear
local
exclud
downstream
analysi
result
select
partner
test
role
hcv
infect
protein
interact
public
submit
imex
http
wwwimexconsortiumorg
consortium
intact
assign
identifi
orchard
et
al
cell
stabli
express
firefli
luciferas
fluc
transfect
pool
three
sirna
select
transient
interact
partner
ambion
silenc
select
infect
renilla
luciferas
report
viru
moi
detail
supplement
experiment
procedur
screen
perform
nine
time
fluc
cell
three
independ
passag
normal
statist
analysi
perform
set
target
total
r
use
bioconductor
packag
rnaither
rieber
et
al
e
cell
infect
hcv
clone
moi
left
uninfect
hpi
cell
fix
stain
describ
figur
scare
bar
primari
human
hepatocyt
isol
liver
specimen
obtain
partial
hepatectomi
plate
collagen
densiti
cell
dish
describ
klein
et
al
onestep
immunoprecipit
membran
protein
perform
adapt
protocol
schneider
et
al
protein
denatur
reduc
alkyl
digest
trypsin
describ
butter
et
al
meissner
et
al
peptid
separ
hplc
min
gradient
acetonitril
analyz
orbitrap
elit
mass
spectromet
thermo
fisher
scientif
fullscan
ms
acquir
resolut
orbitrap
analyz
tenmost
intens
ion
full
scan
fragment
collisioninduc
dissoci
analyz
linear
ion
trap
mass
spectra
analyz
use
maxquant
softwar
version
carbamidomethylcystein
set
fix
modif
ntermin
acetyl
methionin
oxid
variabl
modif
spectra
search
andromeda
search
engin
human
intern
protein
index
protein
sequenc
databas
ipi
version
combin
common
contamin
concaten
revers
version
sequenc
protein
identif
requir
least
one
uniqu
razor
peptid
per
protein
group
requir
fals
posit
rate
set
peptid
protein
level
minimum
requir
peptid
length
set
amino
acid
contamin
revers
identif
protein
identifi
site
exclud
data
analysi
perform
perseu
perform
function
annot
cluster
enrich
score
silac
hit
use
panther
thoma
et
al
david
analysi
yield
highli
enrich
cluster
eas
score
cluster
total
next
gener
combin
network
view
base
string
databas
interact
david
function
annot
cluster
use
matlab
script
describ
mercer
et
al
cytoscap
visual
briefli
use
string
http
wwwstringdborg
gener
interact
network
signific
silac
hit
stronger
dynam
interact
franceschini
et
al
protein
assign
cluster
highest
enrich
protein
present
highest
fraction
individu
annot
select
unclust
protein
place
back
visual
invert
arrowhead
string
interact
solid
line
confid
score
higher
interact
higher
gene
within
function
annot
cluster
ad
final
manual
place
function
annot
cluster
approxim
cellular
locat
select
protein
two
cellular
locat
place
respect
place
see
figur
cell
stabli
express
firefli
luciferas
fluc
seed
densiti
cell
per
well
well
plate
h
prior
transfect
gentzsch
et
al
rna
interfer
dynam
interact
partner
achiev
pool
three
independ
target
sirna
ambion
silenc
select
avail
valid
sirna
select
two
scrambl
sirna
serv
neg
pool
three
target
sirna
posit
control
avoid
plate
effect
four
scrambl
control
randomli
posit
plate
edg
left
untreat
transfect
pmole
sirna
per
well
use
lipofectamin
rnaimax
invitrogen
accord
manufactur
instruct
cell
infect
renilla
luciferas
report
viru
h
post
transfect
moi
inoculum
replac
medium
h
later
infect
assay
hpi
quantif
firefli
renilla
luciferas
activ
residu
plate
effect
comput
account
normal
scrambl
control
read
observ
effect
cell
prolifer
viabil
target
sirna
pool
sirna
pool
reduc
cell
prolifer
accord
describ
prolif
role
oren
et
al
order
elimin
prolifer
depend
effect
specif
hcv
infect
calcul
normal
renilla
luciferas
activ
infect
readout
firefli
luciferas
activ
viabil
readout
fluc
cell
electropor
hcv
rna
plate
well
dish
gentzsch
et
al
transfect
pool
three
sirna
replic
hcv
replic
well
assembl
releas
quantifi
assay
renilla
luciferas
activ
produc
receiv
cell
lysat
cell
viabil
assess
firefli
luciferas
activ
measur
lysat
assembl
releas
valu
normal
replic
valu
exclud
impair
replic
would
influenc
assembl
releas
readout
cell
transduc
lentivir
pseudoparticl
encod
firefli
luciferas
h
post
sirna
silenc
luciferas
activ
determin
hcvpp
specif
infect
calcul
normal
vsv
pseudotyp
scambl
sirna
control
assay
endosom
acidif
independ
hcv
uptak
adapt
previous
describ
membran
fusion
assay
bitzegeio
et
al
tschern
et
al
briefli
cell
plate
densiti
cell
per
polylysin
treat
dish
transfect
nm
concanamycin
prevent
acidif
endosom
compart
therebi
block
natur
rout
hcv
entri
concentr
viru
hcv
vsvfluc
allow
bind
cell
h
presenc
concanamycin
two
pb
wash
cell
shift
h
continu
presenc
concanamycin
allow
glycoprotein
prime
membran
fusion
induc
min
wash
ph
citric
acid
buffer
background
infect
assess
min
wash
ph
citric
acid
buffer
complet
viru
uptak
cell
incub
addit
h
medium
contain
concanamycin
medium
replac
luciferas
activ
measur
hpi
vsvfluc
hpi
hcv
pirf
bicistron
report
plasmid
kindli
provid
anni
cahour
jean
dubuisson
yve
rouill
vitro
transcrib
cap
describ
laport
et
al
full
length
subgenom
hcv
construct
polymeras
defici
mutant
transcrib
describ
previous
cell
lipofect
ug
rna
per
translat
activ
measur
h
assess
luciferas
activ
cell
lysat
